Table 5.
Effect of HBEO and HBEON on hepatic and renal antioxidant enzymes in rats treated with TiO2-NPs
| Parameter groups | GPx (U/g) | CAT (mU/g) | SOD (U/g) | |||
|---|---|---|---|---|---|---|
| Liver | Kidney | Liver | Kidney | Liver | Kidney | |
| Control | 36.45 ± 1.07a | 31.30 ± 0.98a | 6.56 ± 0.08a | 7.88 ± 0.15a | 28.14 ± 0.65aa | 28.19 ± 0.50a |
| HBEO | 39.49 ± 2.24b | 33.49 ± 1.13b | 7.02 ± 0.10a | 8.05 ± 0.08b | 29.89 ± 0.77a | 29.93 ± 0.42a |
| HEBEON | 41.25 ± 2.51b | 35.63 ± 0.45c | 7.16 ± 0.05a | 9.22 ± 0.26c | 29.87 ± 0.49a | 28.43 ± 1.04a |
| TiO2-NPs | 21.43 ± 0.55c | 12.02 ± 0.57d | 2.87 ± 0.15b | 3.46 ± 0.15d | 14.24 ± 0.15b | 15.02 ± 0.25b |
| TiO2-NPs + HBEO | 27.41 ± 0.78d | 17.38 ± 0.24e | 4.33 ± 0.09c | 5.31 ± 0.05e | 17.73 ± 0.34c | 18.86 ± 0.34c |
| TiO2-NPs + HBEON | 30.82 ± 0.46f | 23.68 ± 0.54f | 5.01 ± 0.07d | 5.54 ± 0.08e | 21.45 ± 0.54d | 20.73 ± 0.27d |
Within each column, means superscript with different letters are significantly different (p<0.05)